Diametric Capital’s AstraZeneca AZN Stock Holding History

Diametric Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13,877	Closed	-$1.47M	–	125
2020 Q2	$1.47M	Buy	+13,877	New	+$1.43M	1.13%	29
2019 Q4	–	Sell	-9,789	Closed	-$873K	–	127
2019 Q3	$873K	Buy	+9,789	New	+$849K	0.72%	49
2019 Q2	–	Sell	-25,941	Closed	-$2.1M	–	126
2019 Q1	$2.1M	Sell	25,941 -6,744	-21%	-$532K	1.65%	16
2018 Q4	$2.48M	Buy	32,685 +7,472	+30%	+$583K	1.92%	14
2018 Q3	$2M	Buy	+25,213	New	+$1.91M	1.74%	17

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Diametric Capital's AZN Position: Q3 2020 in Review

Diametric Capital sold out of AstraZeneca (AZN) in Q3 2020, closing a stake of 13,877 shares — an estimated $1.47M sold.

Diametric Capital first reported a position in AZN in Q3 2018 and held it in 5 quarters. The position peaked at $2.48M in Q4 2018. 722 funds tracked by Wall St. Rank hold AZN as of Q3 2020.

Diametric Capital reported no remaining AstraZeneca position as of Q3 2020 after selling out during the quarter.
Diametric Capital sold 13,877 AstraZeneca shares in Q3 2020, an estimated $1.47M.
Diametric Capital first reported a position in AstraZeneca in Q3 2018 and held it in 5 quarters.
Diametric Capital's AstraZeneca position peaked at $2.48M in Q4 2018.
722 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2020.

Based on Diametric Capital's 13F filing for Q3 2020, filed 13 Nov 2020.